Related Experiment Videos
On the toxicity of valproic-acid
M Moreiras Plaza1, G Rodríguez Goyanes, L Cuiña
1Department of Nephrology, Xeral-Cies Hospital, Vigo, Spain.
Clinical Nephrology
|April 1, 1999
Summary
Valproic acid can cause pancreatitis, a serious side effect. In dialysis patients, end-stage renal disease may increase the risk of valproic acid-induced pancreatitis.
Area of Science:
- Nephrology
- Pharmacology
- Gastroenterology
Background:
- Valproic acid (VPA) is an anticonvulsant and mood-stabilizing drug.
- VPA is associated with a risk of pancreatitis, a severe adverse effect.
- Patients with chronic kidney disease, particularly those on dialysis, require careful medication management.
Observation:
- A case of acute pancreatitis is presented in a patient undergoing dialysis.
- The patient was receiving valproic acid therapy.
- This case highlights a potential link between VPA and pancreatitis in renal patients.
Findings:
- Valproic acid-induced pancreatitis is a recognized but uncommon adverse drug reaction.
- The study suggests that end-stage renal disease (ESRD) may represent an additional risk factor for VPA-induced pancreatitis.
- Existing literature on VPA toxicity and pancreatitis in renal impairment is reviewed.
Implications:
- Clinicians should consider VPA-induced pancreatitis in dialysis patients presenting with abdominal pain.
- End-stage renal disease may necessitate closer monitoring for VPA-related complications.
- Further research is warranted to elucidate the mechanisms and prevalence of VPA-induced pancreatitis in ESRD patients.